ATOMIC-Meso

Trial description
Randomized, Double-Blind Phase 2/3 Study in Subjects with Malignant Pleural Mesothelioma with Low Argininosuccinate Synthetase 1 Expression to Assess ADI-PEG 20 with Pemetrexed and Cisplatin
Contact name
Dr David Gilligan
Trial start date
Monday, March 5, 2018
Trial end date
Friday, January 25, 2019
Trial tumour type
Lung
Show on Radiotherapy
No